Skip to main content

Table 1 The main characteristics of the included studies

From: Genetic polymorphisms of CYP24A1 gene and cancer susceptibility: a meta-analysis including 40640 subjects

First author

Year

Country

Ethnicity

Cancer type

Sample size

Case

Controls

HWE (control)

Case

Control

AA

AB

BB

AA

AB

BB

rs2296241

 Holt a

2009

USA

Caucasian

Prostate cancer

692

705

166

356

170

151

371

183

0.147

 Holt b

2009

USA

African

Prostate cancer

112

66

25

50

37

12

39

15

0.134

 Wu

2017

China

Asian

Lung cancer

426

445

119

230

77

114

227

104

0.662

 Holick

2007

UK

Caucasian

Prostate cancer

571

539

134

285

152

107

275

157

0.497

 McCullough

2007

USA

Caucasian

Breast cancer

494

490

99

254

141

98

253

139

0.377

 Penna-Martinez PTC

2012

Germany

Caucasian

Thyroid carcinoma

205

302

47

101

57

62

151

89

0.889

 Penna-Martinez FTC

2012

Germany

Caucasian

Thyroid carcinoma

48

302

17

22

9

62

151

89

0.889

 Yang

2017

China

Asian

ESCC

569

556

116

263

190

113

292

151

0.192

 Anderson

2011

Canada

Caucasian

Breast cancer

1556

1630

330

777

449

371

791

468

0.294

 Oh

2009

Korea

Asian

Prostate cancer

272

173

64(A%)

36(B%)

 

55.8(A%)

44.2(B%)

  

 Beuten

2011

USA

Caucasian

Prostate cancer

609

348

48.4(A%)

51.6(B%)

 

47(A%)

53(B%)

  

 Beuten

2011

USA

Caucasian

Prostate cancer

195

514

55.4(A%)

44.6(B%)

 

55.9(A%)

44.1(B%)

  

 Beuten

2011

USA

African

Prostate cancer

82

109

54.9(A%)

45.1(B%)

 

49.7(A%)

50.3(B%)

  

rs4809957

 Anderson

2013

Canada

Caucasian

Pancreas cancer

627

1189

362

232

33

749

377

63

0.088

 Zhuo

2018

China

Asian

Lung cancer

322

384

124

152

46

143

185

56

0.759

 Gong

2017

China

Asian

Colorectal cancer

524

595

206

260

58

230

295

70

0.093

 Wei

2019

China

Asian

Breast cancer

378

402

134

180

64

162

197

43

0.144

rs2762939

 Holt a

2009

USA

Caucasian

Prostate cancer

702

715

380

272

50

376

294

45

0.324

 Holt b

2009

USA

African

Prostate cancer

114

67

29

48

37

13

32

22

0.824

 Wu

2017

China

Asian

Lung cancer

426

445

160

192

74

156

220

69

0.553

 Holick

2007

UK

Caucasian

Prostate cancer

568

539

319

212

37

300

196

43

0.173

 Reimers

2015

USA

Caucasian

Breast cancer

921

970

514

348

59

560

353

57

0.889

rs4809960

 Holick

2007

UK

Caucasian

Prostate cancer

586

544

329

230

27

323

184

37

0.129

 Holt a

2009

USA

Caucasian

Prostate cancer

697

693

432

220

45

387

260

46

0.794

 Holt b

2009

USA

African

Prostate cancer

112

63

93

18

1

46

17

0

0.216

 Reimers

2015

USA

Caucasian

Breast cancer

948

989

522

342

84

512

395

82

0.637

 Clendenen

2015

Sweden

Caucasian

Breast cancer

733

1433

479

218

36

861

496

76

0.679

 Sadeghi

2020

Iran

Caucasian

Colorectal cancer

220

243

119

95

6

105

119

19

0.062

 Yi

2019

China

Asian

Colorectal cancer

787

800

415

311

61

468

290

42

0.736

rs6068816

 Holick

2007

UK

Caucasian

Prostate cancer

583

544

454

118

11

443

93

8

0.227

 Holt a

2009

USA

Caucasian

Prostate Cancer

699

712

558

135

6

580

127

5

0.493

 Reimers

2015

USA

Caucasian

Breast cancer

948

990

778

164

6

784

189

17

0.158

 Clendenen

2015

Sweden

Caucasian

Breast cancer

733

1432

590

136

7

1149

264

19

0.389

 Yi

2019

China

Asian

Colorectal cancer

787

800

342

354

91

362

348

90

0.645

 Qu

2019

China

Asian

Lung cancer

345

351

160

155

30

131

178

42

0.116

  1. HWE Hardy–Weinberg equilibrium, ESCC Esophageal squamous cell carcinoma, a Caucasian population, b African population, A wild type allele, B Mutated type allele